| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 0.00% |
| NAV | ₹10.52 (30 Oct 2020) |
|---|---|
| Fund Started | 08 Dec 2017 |
| Fund Size | ₹628 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Infosys Ltd. | Technology | Equity | 9.5% |
| Multi Commodity Exchange India | Financial | Equity | 7.4% |
| ICICI Bank Ltd. | Financial | Equity | 6.7% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 6.2% |
| Crompton Greaves Consumer Electricals Ltd. | Cons Durable | Equity | 6.0% |
| Cipla Ltd. | Healthcare | Equity | 6.0% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 5.2% |
| Eicher Motors Ltd. | Automobile | Equity | 5.0% |
| Gujarat Gas Ltd. | Chemicals | Equity | 4.8% |
| Axis Bank Ltd. | Financial | Equity | 4.5% |
UTI Focussed Equity Fund Series V (1102 Days) Direct Dividend is a Equity Mutual Fund Scheme launched by Axis Mutual Fund. This scheme was made available to investors on 08 Dec 2017. Vetri Subramaniam, Sachin Trivedi is the Current Fund Manager of UTI Focussed Equity Fund Series V (1102 Days) Direct Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹628 Cr and the Latest NAV as of 30 Oct 2020 is ₹10.52.
The UTI Focussed Equity Fund Series V (1102 Days) Direct Dividend is rated Moderately High risk.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of listed companies. The scheme will without any capitalization bias endeavour to invest in either growth stocks or value stocks or both. The Scheme will normally hold upto 30 stocks in the portfolio.